Imunon

IMNNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.765 M

$1.61 +1.90%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

$14.5M

#1977 by earnings

Shares outstanding

3,922,764

Latest filing cover page

P/E ratio

0.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#453Xtl BiopharmaceuticalsXTLB$7.22M
#454Cadrenal TherapeuticsCVKD$6.96M
#455ImunonIMNN$6.77M
#456Acurx PharmaceuticalsACXP$6.62M
#457Alzamend NeuroALZN$6.56M

Where these numbers come from

Share counts and financials for Imunon are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.